Recurrent membranoproliferative glomerulonephritis type i after kidney transplantation: A 17-Year single-center experience

Transplantation

Volumn 99, Issue 6, 2015, Pages 1172-1177

  Green, Hefziba ^a,b   Rahamimov, Ruth ^a,b   Rozen Zvi, Benaya ^a,b   Pertzov, Barak ^a   Tobar, Ana ^a,b   Lichtenberg, Shelly ^a   Gafter, Uzi ^a,b   Mor, Eytan ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA B49 ANTIGEN; HLA DR4 ANTIGEN; UNCLASSIFIED DRUG; HLA ANTIGEN; HLA-B*49 ANTIGEN;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARAB; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; DIALYSIS; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HIGH RISK POPULATION; HUMAN; JEW; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE 1; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREND STUDY; UNRELATED DONORS; WORK EXPERIENCE; ADVERSE EFFECTS; GENETICS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GRAFT REJECTION; IMMUNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; RISK FACTOR; YOUNG ADULT;

ADULT; COHORT STUDIES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HLA-B ANTIGENS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84930516863     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000459     Document Type: Article

References (22)

1. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis-A new look at an old entity. N Engl J Med 2012;366:1119.
2. Little MA, Dupont P, Campbell E, et al. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 2006;69:504.
3. Schmitt H, Bohle A, Reineke T, et al. Long term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: A investigation of 22 cases. Nephron 1990;55(3):242.
4. Cameron JS, Turner DR, Heaton J, et al. Idiopathic mesangiocapillary glomerulonephritis. Comparison of type I and II in children and adults and long term prognosis. Am J Med 1983;74:175.
5. Angelo JR, Bell CS, Braun MC. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Am J Kidney Dis 2011;57:291.
6. O'Meara Y, Green A, Carmody M, et al. Recurrent glomerulonephritis in renal transplants: fourteen years' experience. Neprhol Dial Transplant 1989;4:730.
7. Andresdottir MB, Assmann KJ, Hoitsma AJ, Koene RA, Wetzels JF. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: Analysis of the incidence, risk factors and impact on graft survival. Transplantation 1997;63(11):1628.
8. Moroni G, Casati C, Quaglini S, et al. Membranoproliferative glomerulonephritis type I in renal transplantation patients: A single center study of a cohort of 68 renal transplants followed up for 11 years. Transplantation 2011;91:1233.
9. Toledo K, Perez-Saez MJ, Navarro MD, et al. Impact of recurrent glomerulonephritis on renal graft survival. Transplant Proc 2011;43:2182.
10. Lorenz EC, Sethi S, Leung N, et al. Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int 2010;77:721.
11. Moritz MJ, Burke JF, Jarrell BE, et al. The incidence of membranoproliferative glomerulonephritis in renal allografts. Transplant Proc 1987;19:2206.
12. Mathew TH, Mathews DC, Hobbs JB, et al. Glomerular lesions after renal transplantation. Am J Med 1975;59:177.
13. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605.
14. Siddiqi N, McBride MA, Hariharan S. Similar risk profiles for posttransplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int 2004;65:1906.
15. Freitas MC. Kidney transplantation in the US: An analysis of the OPTN/ UNOS registry. Clin Transpl 2011:1.
16. Gonzalez-Galarza FF, Christmas S, Middleton D, et al. Allele frequency net: A database and online repository for immune gene frequencies in worldwide populations. Nucleic Acid Res 2011;39:D913.
17. Orhan Y, Azezli A, Çarin M, et al. Human lymphocyte antigens(HLA) and Graves' disease in Turkey. J Clin Immunol 1993;13:339.
18. Nomoto Y, Endoh M, Miura M, et al. IgA nephropathy associated with HLA-DR4 antigen. Am J Nephrol 1984;4:184.
19. Hiki Y, Kobayashi Y, Ookubo M, et al. The role of HLA-DR4 in the longterm prognosis of IgA nephropathy. Nephron 1990;54:264.
20. Boki A, Drosos AA, Tzioufas AG, et al. Examination of HLA-DR4 as a severity marker forrheumatoid arthritis in Greek patients. Ann Rheum Dis 1993;52:517.
21. Welch TR, Beischel L, Balakrishnan K, et al. Major-histocompatibilitycomplex extended haplotypes in membranoproliferative glomerulonephritis. N Engl JMed 1986;314:1476.
22. Kari JA. Early presentation of membranoproliferative glomrulonephritis in Arab children. Saudi Med J 2003;24:157.